SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=917114, encodeId=5a1c91e11405, content=投稿后被回退：Kindly move the abstract section to the title page. All figure legends should be in order at the end of the text Word doc. They should not be embedded in the actual figures. 不知什么意思，我的图片说明是放在正文最后的，在上传的figure文件中仅仅是以FIG1,FIG2标示，不知要怎样修改, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e9182336216, createdName=1227e9cbm83(暂无昵称), createdTime=Sat Jan 16 10:20:24 CST 2021, time=2021-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221818, encodeId=fb08122181853, content=最近有中稿的同学吗？现在审稿多久呀，从投到接收大概多久呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220217/8786d50a2431425cbaf7dbc437d277a8/068b2a75786546cd8b23afd9cdc1d37b.jpeg, createdBy=30b74770079, createdName=皮卡皮卡丘, createdTime=Mon May 23 18:57:04 CST 2022, time=2022-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196394, encodeId=c7ba119639409, content=编辑发邮件表示接收并小修，但是邮件里没有提及具体修改的内容，有大佬知道这种情况该怎么办嘛？（已经发过邮件给编辑询问，目前尚无回信）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7b55491270, createdName=yh2, createdTime=Wed Feb 23 13:17:57 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585262, encodeId=975758526257, content=我用在线系统写了两次催稿信，都没有收到回复，求有经验的人指导。一审已经6个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/V1uic8zIRFmrJYfiboenkCicTleYZVXOYQjOiabDgCpFEe9MEASIDy7JBZw1nmgyjG4S69uVQmia7D1lCT1L68ibzvvQ/132, createdBy=950f2163075, createdName=蓝天lzx, createdTime=Mon Feb 24 00:00:00 CST 2020, time=2020-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223113, encodeId=b2db12231137c, content=这个杂志需要的ICMJE表格，one file for each author这是什么意思？每个作者要提交什么啊？😂😅, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23ba8179104, createdName=ms7000001443037924, createdTime=Sun May 29 10:25:09 CST 2022, time=2022-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220163, encodeId=9be2122016386, content=请问这个期刊可以共同通讯作者吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b428152394, createdName=ms2000000257812233, createdTime=Mon May 16 23:55:08 CST 2022, time=2022-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574125, encodeId=a9945e4125e6, content=请问所有的临床实验，都需要注册号吗？非RCT也要？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/V1uic8zIRFmrJYfiboenkCicTleYZVXOYQjOiabDgCpFEe9MEASIDy7JBZw1nmgyjG4S69uVQmia7D1lCT1L68ibzvvQ/132, createdBy=950f2163075, createdName=蓝天lzx, createdTime=Sun Jul 28 00:00:00 CST 2019, time=2019-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1215644, encodeId=9c1e121564402, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：感觉编辑还是很友好的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2b82054649, createdName=果果乖贝儿, createdTime=Fri Apr 29 18:44:29 CST 2022, time=2022-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196399, encodeId=be84119639985, content=请问下有提交不能创建PDf的同学嘛，各位是怎么解决的啊，跪求, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=56145605225, createdName=ms2000001619512986, createdTime=Wed Feb 23 13:28:04 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196403, encodeId=02f71196403fd, content=请问下各位有遇到投稿不能创建PDF的情况吗？跪求解决方案, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=56145605225, createdName=ms2000001619512986, createdTime=Wed Feb 23 13:30:55 CST 2022, time=2022-02-23, status=1, ipAttribution=)]

2021-01-16 1227e9cbm83(暂无昵称)

投稿后被回退：Kindly move the abstract section to the title page.
All figure legends should be in order at the end of the text Word doc. They should not be embedded in the actual figures.
不知什么意思，我的图片说明是放在正文最后的，在上传的figure文件中仅仅是以FIG1,FIG2标示，不知要怎样修改

92 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=917114, encodeId=5a1c91e11405, content=投稿后被回退：Kindly move the abstract section to the title page. All figure legends should be in order at the end of the text Word doc. They should not be embedded in the actual figures. 不知什么意思，我的图片说明是放在正文最后的，在上传的figure文件中仅仅是以FIG1,FIG2标示，不知要怎样修改, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e9182336216, createdName=1227e9cbm83(暂无昵称), createdTime=Sat Jan 16 10:20:24 CST 2021, time=2021-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221818, encodeId=fb08122181853, content=最近有中稿的同学吗？现在审稿多久呀，从投到接收大概多久呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220217/8786d50a2431425cbaf7dbc437d277a8/068b2a75786546cd8b23afd9cdc1d37b.jpeg, createdBy=30b74770079, createdName=皮卡皮卡丘, createdTime=Mon May 23 18:57:04 CST 2022, time=2022-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196394, encodeId=c7ba119639409, content=编辑发邮件表示接收并小修，但是邮件里没有提及具体修改的内容，有大佬知道这种情况该怎么办嘛？（已经发过邮件给编辑询问，目前尚无回信）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7b55491270, createdName=yh2, createdTime=Wed Feb 23 13:17:57 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585262, encodeId=975758526257, content=我用在线系统写了两次催稿信，都没有收到回复，求有经验的人指导。一审已经6个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/V1uic8zIRFmrJYfiboenkCicTleYZVXOYQjOiabDgCpFEe9MEASIDy7JBZw1nmgyjG4S69uVQmia7D1lCT1L68ibzvvQ/132, createdBy=950f2163075, createdName=蓝天lzx, createdTime=Mon Feb 24 00:00:00 CST 2020, time=2020-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223113, encodeId=b2db12231137c, content=这个杂志需要的ICMJE表格，one file for each author这是什么意思？每个作者要提交什么啊？😂😅, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23ba8179104, createdName=ms7000001443037924, createdTime=Sun May 29 10:25:09 CST 2022, time=2022-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220163, encodeId=9be2122016386, content=请问这个期刊可以共同通讯作者吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b428152394, createdName=ms2000000257812233, createdTime=Mon May 16 23:55:08 CST 2022, time=2022-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574125, encodeId=a9945e4125e6, content=请问所有的临床实验，都需要注册号吗？非RCT也要？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/V1uic8zIRFmrJYfiboenkCicTleYZVXOYQjOiabDgCpFEe9MEASIDy7JBZw1nmgyjG4S69uVQmia7D1lCT1L68ibzvvQ/132, createdBy=950f2163075, createdName=蓝天lzx, createdTime=Sun Jul 28 00:00:00 CST 2019, time=2019-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1215644, encodeId=9c1e121564402, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：感觉编辑还是很友好的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2b82054649, createdName=果果乖贝儿, createdTime=Fri Apr 29 18:44:29 CST 2022, time=2022-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196399, encodeId=be84119639985, content=请问下有提交不能创建PDf的同学嘛，各位是怎么解决的啊，跪求, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=56145605225, createdName=ms2000001619512986, createdTime=Wed Feb 23 13:28:04 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196403, encodeId=02f71196403fd, content=请问下各位有遇到投稿不能创建PDF的情况吗？跪求解决方案, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=56145605225, createdName=ms2000001619512986, createdTime=Wed Feb 23 13:30:55 CST 2022, time=2022-02-23, status=1, ipAttribution=)]

2022-05-23 皮卡皮卡丘

最近有中稿的同学吗？现在审稿多久呀，从投到接收大概多久呢

21 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=917114, encodeId=5a1c91e11405, content=投稿后被回退：Kindly move the abstract section to the title page. All figure legends should be in order at the end of the text Word doc. They should not be embedded in the actual figures. 不知什么意思，我的图片说明是放在正文最后的，在上传的figure文件中仅仅是以FIG1,FIG2标示，不知要怎样修改, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e9182336216, createdName=1227e9cbm83(暂无昵称), createdTime=Sat Jan 16 10:20:24 CST 2021, time=2021-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221818, encodeId=fb08122181853, content=最近有中稿的同学吗？现在审稿多久呀，从投到接收大概多久呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220217/8786d50a2431425cbaf7dbc437d277a8/068b2a75786546cd8b23afd9cdc1d37b.jpeg, createdBy=30b74770079, createdName=皮卡皮卡丘, createdTime=Mon May 23 18:57:04 CST 2022, time=2022-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196394, encodeId=c7ba119639409, content=编辑发邮件表示接收并小修，但是邮件里没有提及具体修改的内容，有大佬知道这种情况该怎么办嘛？（已经发过邮件给编辑询问，目前尚无回信）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7b55491270, createdName=yh2, createdTime=Wed Feb 23 13:17:57 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585262, encodeId=975758526257, content=我用在线系统写了两次催稿信，都没有收到回复，求有经验的人指导。一审已经6个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/V1uic8zIRFmrJYfiboenkCicTleYZVXOYQjOiabDgCpFEe9MEASIDy7JBZw1nmgyjG4S69uVQmia7D1lCT1L68ibzvvQ/132, createdBy=950f2163075, createdName=蓝天lzx, createdTime=Mon Feb 24 00:00:00 CST 2020, time=2020-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223113, encodeId=b2db12231137c, content=这个杂志需要的ICMJE表格，one file for each author这是什么意思？每个作者要提交什么啊？😂😅, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23ba8179104, createdName=ms7000001443037924, createdTime=Sun May 29 10:25:09 CST 2022, time=2022-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220163, encodeId=9be2122016386, content=请问这个期刊可以共同通讯作者吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b428152394, createdName=ms2000000257812233, createdTime=Mon May 16 23:55:08 CST 2022, time=2022-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574125, encodeId=a9945e4125e6, content=请问所有的临床实验，都需要注册号吗？非RCT也要？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/V1uic8zIRFmrJYfiboenkCicTleYZVXOYQjOiabDgCpFEe9MEASIDy7JBZw1nmgyjG4S69uVQmia7D1lCT1L68ibzvvQ/132, createdBy=950f2163075, createdName=蓝天lzx, createdTime=Sun Jul 28 00:00:00 CST 2019, time=2019-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1215644, encodeId=9c1e121564402, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：感觉编辑还是很友好的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2b82054649, createdName=果果乖贝儿, createdTime=Fri Apr 29 18:44:29 CST 2022, time=2022-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196399, encodeId=be84119639985, content=请问下有提交不能创建PDf的同学嘛，各位是怎么解决的啊，跪求, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=56145605225, createdName=ms2000001619512986, createdTime=Wed Feb 23 13:28:04 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196403, encodeId=02f71196403fd, content=请问下各位有遇到投稿不能创建PDF的情况吗？跪求解决方案, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=56145605225, createdName=ms2000001619512986, createdTime=Wed Feb 23 13:30:55 CST 2022, time=2022-02-23, status=1, ipAttribution=)]

2022-02-23 yh2

编辑发邮件表示接收并小修，但是邮件里没有提及具体修改的内容，有大佬知道这种情况该怎么办嘛？（已经发过邮件给编辑询问，目前尚无回信）

38 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=917114, encodeId=5a1c91e11405, content=投稿后被回退：Kindly move the abstract section to the title page. All figure legends should be in order at the end of the text Word doc. They should not be embedded in the actual figures. 不知什么意思，我的图片说明是放在正文最后的，在上传的figure文件中仅仅是以FIG1,FIG2标示，不知要怎样修改, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e9182336216, createdName=1227e9cbm83(暂无昵称), createdTime=Sat Jan 16 10:20:24 CST 2021, time=2021-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221818, encodeId=fb08122181853, content=最近有中稿的同学吗？现在审稿多久呀，从投到接收大概多久呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220217/8786d50a2431425cbaf7dbc437d277a8/068b2a75786546cd8b23afd9cdc1d37b.jpeg, createdBy=30b74770079, createdName=皮卡皮卡丘, createdTime=Mon May 23 18:57:04 CST 2022, time=2022-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196394, encodeId=c7ba119639409, content=编辑发邮件表示接收并小修，但是邮件里没有提及具体修改的内容，有大佬知道这种情况该怎么办嘛？（已经发过邮件给编辑询问，目前尚无回信）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7b55491270, createdName=yh2, createdTime=Wed Feb 23 13:17:57 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585262, encodeId=975758526257, content=我用在线系统写了两次催稿信，都没有收到回复，求有经验的人指导。一审已经6个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/V1uic8zIRFmrJYfiboenkCicTleYZVXOYQjOiabDgCpFEe9MEASIDy7JBZw1nmgyjG4S69uVQmia7D1lCT1L68ibzvvQ/132, createdBy=950f2163075, createdName=蓝天lzx, createdTime=Mon Feb 24 00:00:00 CST 2020, time=2020-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223113, encodeId=b2db12231137c, content=这个杂志需要的ICMJE表格，one file for each author这是什么意思？每个作者要提交什么啊？😂😅, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23ba8179104, createdName=ms7000001443037924, createdTime=Sun May 29 10:25:09 CST 2022, time=2022-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220163, encodeId=9be2122016386, content=请问这个期刊可以共同通讯作者吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b428152394, createdName=ms2000000257812233, createdTime=Mon May 16 23:55:08 CST 2022, time=2022-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574125, encodeId=a9945e4125e6, content=请问所有的临床实验，都需要注册号吗？非RCT也要？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/V1uic8zIRFmrJYfiboenkCicTleYZVXOYQjOiabDgCpFEe9MEASIDy7JBZw1nmgyjG4S69uVQmia7D1lCT1L68ibzvvQ/132, createdBy=950f2163075, createdName=蓝天lzx, createdTime=Sun Jul 28 00:00:00 CST 2019, time=2019-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1215644, encodeId=9c1e121564402, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：感觉编辑还是很友好的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2b82054649, createdName=果果乖贝儿, createdTime=Fri Apr 29 18:44:29 CST 2022, time=2022-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196399, encodeId=be84119639985, content=请问下有提交不能创建PDf的同学嘛，各位是怎么解决的啊，跪求, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=56145605225, createdName=ms2000001619512986, createdTime=Wed Feb 23 13:28:04 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196403, encodeId=02f71196403fd, content=请问下各位有遇到投稿不能创建PDF的情况吗？跪求解决方案, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=56145605225, createdName=ms2000001619512986, createdTime=Wed Feb 23 13:30:55 CST 2022, time=2022-02-23, status=1, ipAttribution=)]

2020-02-24 蓝天lzx

我用在线系统写了两次催稿信，都没有收到回复，求有经验的人指导。一审已经6个月了

20 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=917114, encodeId=5a1c91e11405, content=投稿后被回退：Kindly move the abstract section to the title page. All figure legends should be in order at the end of the text Word doc. They should not be embedded in the actual figures. 不知什么意思，我的图片说明是放在正文最后的，在上传的figure文件中仅仅是以FIG1,FIG2标示，不知要怎样修改, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e9182336216, createdName=1227e9cbm83(暂无昵称), createdTime=Sat Jan 16 10:20:24 CST 2021, time=2021-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221818, encodeId=fb08122181853, content=最近有中稿的同学吗？现在审稿多久呀，从投到接收大概多久呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220217/8786d50a2431425cbaf7dbc437d277a8/068b2a75786546cd8b23afd9cdc1d37b.jpeg, createdBy=30b74770079, createdName=皮卡皮卡丘, createdTime=Mon May 23 18:57:04 CST 2022, time=2022-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196394, encodeId=c7ba119639409, content=编辑发邮件表示接收并小修，但是邮件里没有提及具体修改的内容，有大佬知道这种情况该怎么办嘛？（已经发过邮件给编辑询问，目前尚无回信）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7b55491270, createdName=yh2, createdTime=Wed Feb 23 13:17:57 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585262, encodeId=975758526257, content=我用在线系统写了两次催稿信，都没有收到回复，求有经验的人指导。一审已经6个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/V1uic8zIRFmrJYfiboenkCicTleYZVXOYQjOiabDgCpFEe9MEASIDy7JBZw1nmgyjG4S69uVQmia7D1lCT1L68ibzvvQ/132, createdBy=950f2163075, createdName=蓝天lzx, createdTime=Mon Feb 24 00:00:00 CST 2020, time=2020-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223113, encodeId=b2db12231137c, content=这个杂志需要的ICMJE表格，one file for each author这是什么意思？每个作者要提交什么啊？😂😅, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23ba8179104, createdName=ms7000001443037924, createdTime=Sun May 29 10:25:09 CST 2022, time=2022-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220163, encodeId=9be2122016386, content=请问这个期刊可以共同通讯作者吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b428152394, createdName=ms2000000257812233, createdTime=Mon May 16 23:55:08 CST 2022, time=2022-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574125, encodeId=a9945e4125e6, content=请问所有的临床实验，都需要注册号吗？非RCT也要？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/V1uic8zIRFmrJYfiboenkCicTleYZVXOYQjOiabDgCpFEe9MEASIDy7JBZw1nmgyjG4S69uVQmia7D1lCT1L68ibzvvQ/132, createdBy=950f2163075, createdName=蓝天lzx, createdTime=Sun Jul 28 00:00:00 CST 2019, time=2019-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1215644, encodeId=9c1e121564402, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：感觉编辑还是很友好的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2b82054649, createdName=果果乖贝儿, createdTime=Fri Apr 29 18:44:29 CST 2022, time=2022-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196399, encodeId=be84119639985, content=请问下有提交不能创建PDf的同学嘛，各位是怎么解决的啊，跪求, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=56145605225, createdName=ms2000001619512986, createdTime=Wed Feb 23 13:28:04 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196403, encodeId=02f71196403fd, content=请问下各位有遇到投稿不能创建PDF的情况吗？跪求解决方案, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=56145605225, createdName=ms2000001619512986, createdTime=Wed Feb 23 13:30:55 CST 2022, time=2022-02-23, status=1, ipAttribution=)]

2022-05-29 ms7000001443037924

这个杂志需要的ICMJE表格，one file for each author这是什么意思？每个作者要提交什么啊？😂😅

26 0

[GetPortalCommentsPageByObjectIdResponse(id=917114, encodeId=5a1c91e11405, content=投稿后被回退：Kindly move the abstract section to the title page. All figure legends should be in order at the end of the text Word doc. They should not be embedded in the actual figures. 不知什么意思，我的图片说明是放在正文最后的，在上传的figure文件中仅仅是以FIG1,FIG2标示，不知要怎样修改, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e9182336216, createdName=1227e9cbm83(暂无昵称), createdTime=Sat Jan 16 10:20:24 CST 2021, time=2021-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221818, encodeId=fb08122181853, content=最近有中稿的同学吗？现在审稿多久呀，从投到接收大概多久呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220217/8786d50a2431425cbaf7dbc437d277a8/068b2a75786546cd8b23afd9cdc1d37b.jpeg, createdBy=30b74770079, createdName=皮卡皮卡丘, createdTime=Mon May 23 18:57:04 CST 2022, time=2022-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196394, encodeId=c7ba119639409, content=编辑发邮件表示接收并小修，但是邮件里没有提及具体修改的内容，有大佬知道这种情况该怎么办嘛？（已经发过邮件给编辑询问，目前尚无回信）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7b55491270, createdName=yh2, createdTime=Wed Feb 23 13:17:57 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585262, encodeId=975758526257, content=我用在线系统写了两次催稿信，都没有收到回复，求有经验的人指导。一审已经6个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/V1uic8zIRFmrJYfiboenkCicTleYZVXOYQjOiabDgCpFEe9MEASIDy7JBZw1nmgyjG4S69uVQmia7D1lCT1L68ibzvvQ/132, createdBy=950f2163075, createdName=蓝天lzx, createdTime=Mon Feb 24 00:00:00 CST 2020, time=2020-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223113, encodeId=b2db12231137c, content=这个杂志需要的ICMJE表格，one file for each author这是什么意思？每个作者要提交什么啊？😂😅, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23ba8179104, createdName=ms7000001443037924, createdTime=Sun May 29 10:25:09 CST 2022, time=2022-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220163, encodeId=9be2122016386, content=请问这个期刊可以共同通讯作者吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b428152394, createdName=ms2000000257812233, createdTime=Mon May 16 23:55:08 CST 2022, time=2022-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574125, encodeId=a9945e4125e6, content=请问所有的临床实验，都需要注册号吗？非RCT也要？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/V1uic8zIRFmrJYfiboenkCicTleYZVXOYQjOiabDgCpFEe9MEASIDy7JBZw1nmgyjG4S69uVQmia7D1lCT1L68ibzvvQ/132, createdBy=950f2163075, createdName=蓝天lzx, createdTime=Sun Jul 28 00:00:00 CST 2019, time=2019-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1215644, encodeId=9c1e121564402, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：感觉编辑还是很友好的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2b82054649, createdName=果果乖贝儿, createdTime=Fri Apr 29 18:44:29 CST 2022, time=2022-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196399, encodeId=be84119639985, content=请问下有提交不能创建PDf的同学嘛，各位是怎么解决的啊，跪求, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=56145605225, createdName=ms2000001619512986, createdTime=Wed Feb 23 13:28:04 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196403, encodeId=02f71196403fd, content=请问下各位有遇到投稿不能创建PDF的情况吗？跪求解决方案, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=56145605225, createdName=ms2000001619512986, createdTime=Wed Feb 23 13:30:55 CST 2022, time=2022-02-23, status=1, ipAttribution=)]

2022-05-16 ms2000000257812233

请问这个期刊可以共同通讯作者吗

27 0

[GetPortalCommentsPageByObjectIdResponse(id=917114, encodeId=5a1c91e11405, content=投稿后被回退：Kindly move the abstract section to the title page. All figure legends should be in order at the end of the text Word doc. They should not be embedded in the actual figures. 不知什么意思，我的图片说明是放在正文最后的，在上传的figure文件中仅仅是以FIG1,FIG2标示，不知要怎样修改, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e9182336216, createdName=1227e9cbm83(暂无昵称), createdTime=Sat Jan 16 10:20:24 CST 2021, time=2021-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221818, encodeId=fb08122181853, content=最近有中稿的同学吗？现在审稿多久呀，从投到接收大概多久呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220217/8786d50a2431425cbaf7dbc437d277a8/068b2a75786546cd8b23afd9cdc1d37b.jpeg, createdBy=30b74770079, createdName=皮卡皮卡丘, createdTime=Mon May 23 18:57:04 CST 2022, time=2022-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196394, encodeId=c7ba119639409, content=编辑发邮件表示接收并小修，但是邮件里没有提及具体修改的内容，有大佬知道这种情况该怎么办嘛？（已经发过邮件给编辑询问，目前尚无回信）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7b55491270, createdName=yh2, createdTime=Wed Feb 23 13:17:57 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585262, encodeId=975758526257, content=我用在线系统写了两次催稿信，都没有收到回复，求有经验的人指导。一审已经6个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/V1uic8zIRFmrJYfiboenkCicTleYZVXOYQjOiabDgCpFEe9MEASIDy7JBZw1nmgyjG4S69uVQmia7D1lCT1L68ibzvvQ/132, createdBy=950f2163075, createdName=蓝天lzx, createdTime=Mon Feb 24 00:00:00 CST 2020, time=2020-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223113, encodeId=b2db12231137c, content=这个杂志需要的ICMJE表格，one file for each author这是什么意思？每个作者要提交什么啊？😂😅, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23ba8179104, createdName=ms7000001443037924, createdTime=Sun May 29 10:25:09 CST 2022, time=2022-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220163, encodeId=9be2122016386, content=请问这个期刊可以共同通讯作者吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b428152394, createdName=ms2000000257812233, createdTime=Mon May 16 23:55:08 CST 2022, time=2022-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574125, encodeId=a9945e4125e6, content=请问所有的临床实验，都需要注册号吗？非RCT也要？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/V1uic8zIRFmrJYfiboenkCicTleYZVXOYQjOiabDgCpFEe9MEASIDy7JBZw1nmgyjG4S69uVQmia7D1lCT1L68ibzvvQ/132, createdBy=950f2163075, createdName=蓝天lzx, createdTime=Sun Jul 28 00:00:00 CST 2019, time=2019-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1215644, encodeId=9c1e121564402, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：感觉编辑还是很友好的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2b82054649, createdName=果果乖贝儿, createdTime=Fri Apr 29 18:44:29 CST 2022, time=2022-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196399, encodeId=be84119639985, content=请问下有提交不能创建PDf的同学嘛，各位是怎么解决的啊，跪求, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=56145605225, createdName=ms2000001619512986, createdTime=Wed Feb 23 13:28:04 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196403, encodeId=02f71196403fd, content=请问下各位有遇到投稿不能创建PDF的情况吗？跪求解决方案, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=56145605225, createdName=ms2000001619512986, createdTime=Wed Feb 23 13:30:55 CST 2022, time=2022-02-23, status=1, ipAttribution=)]

2019-07-28 蓝天lzx

请问所有的临床实验，都需要注册号吗？非RCT也要？

99 0

[GetPortalCommentsPageByObjectIdResponse(id=917114, encodeId=5a1c91e11405, content=投稿后被回退：Kindly move the abstract section to the title page. All figure legends should be in order at the end of the text Word doc. They should not be embedded in the actual figures. 不知什么意思，我的图片说明是放在正文最后的，在上传的figure文件中仅仅是以FIG1,FIG2标示，不知要怎样修改, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e9182336216, createdName=1227e9cbm83(暂无昵称), createdTime=Sat Jan 16 10:20:24 CST 2021, time=2021-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221818, encodeId=fb08122181853, content=最近有中稿的同学吗？现在审稿多久呀，从投到接收大概多久呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220217/8786d50a2431425cbaf7dbc437d277a8/068b2a75786546cd8b23afd9cdc1d37b.jpeg, createdBy=30b74770079, createdName=皮卡皮卡丘, createdTime=Mon May 23 18:57:04 CST 2022, time=2022-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196394, encodeId=c7ba119639409, content=编辑发邮件表示接收并小修，但是邮件里没有提及具体修改的内容，有大佬知道这种情况该怎么办嘛？（已经发过邮件给编辑询问，目前尚无回信）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7b55491270, createdName=yh2, createdTime=Wed Feb 23 13:17:57 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585262, encodeId=975758526257, content=我用在线系统写了两次催稿信，都没有收到回复，求有经验的人指导。一审已经6个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/V1uic8zIRFmrJYfiboenkCicTleYZVXOYQjOiabDgCpFEe9MEASIDy7JBZw1nmgyjG4S69uVQmia7D1lCT1L68ibzvvQ/132, createdBy=950f2163075, createdName=蓝天lzx, createdTime=Mon Feb 24 00:00:00 CST 2020, time=2020-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223113, encodeId=b2db12231137c, content=这个杂志需要的ICMJE表格，one file for each author这是什么意思？每个作者要提交什么啊？😂😅, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23ba8179104, createdName=ms7000001443037924, createdTime=Sun May 29 10:25:09 CST 2022, time=2022-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220163, encodeId=9be2122016386, content=请问这个期刊可以共同通讯作者吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b428152394, createdName=ms2000000257812233, createdTime=Mon May 16 23:55:08 CST 2022, time=2022-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574125, encodeId=a9945e4125e6, content=请问所有的临床实验，都需要注册号吗？非RCT也要？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/V1uic8zIRFmrJYfiboenkCicTleYZVXOYQjOiabDgCpFEe9MEASIDy7JBZw1nmgyjG4S69uVQmia7D1lCT1L68ibzvvQ/132, createdBy=950f2163075, createdName=蓝天lzx, createdTime=Sun Jul 28 00:00:00 CST 2019, time=2019-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1215644, encodeId=9c1e121564402, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：感觉编辑还是很友好的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2b82054649, createdName=果果乖贝儿, createdTime=Fri Apr 29 18:44:29 CST 2022, time=2022-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196399, encodeId=be84119639985, content=请问下有提交不能创建PDf的同学嘛，各位是怎么解决的啊，跪求, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=56145605225, createdName=ms2000001619512986, createdTime=Wed Feb 23 13:28:04 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196403, encodeId=02f71196403fd, content=请问下各位有遇到投稿不能创建PDF的情况吗？跪求解决方案, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=56145605225, createdName=ms2000001619512986, createdTime=Wed Feb 23 13:30:55 CST 2022, time=2022-02-23, status=1, ipAttribution=)]

2022-04-29 果果乖贝儿

审稿速度:3.0 | 投稿命中率:50.0
经验分享：感觉编辑还是很友好的

22 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=917114, encodeId=5a1c91e11405, content=投稿后被回退：Kindly move the abstract section to the title page. All figure legends should be in order at the end of the text Word doc. They should not be embedded in the actual figures. 不知什么意思，我的图片说明是放在正文最后的，在上传的figure文件中仅仅是以FIG1,FIG2标示，不知要怎样修改, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e9182336216, createdName=1227e9cbm83(暂无昵称), createdTime=Sat Jan 16 10:20:24 CST 2021, time=2021-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221818, encodeId=fb08122181853, content=最近有中稿的同学吗？现在审稿多久呀，从投到接收大概多久呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220217/8786d50a2431425cbaf7dbc437d277a8/068b2a75786546cd8b23afd9cdc1d37b.jpeg, createdBy=30b74770079, createdName=皮卡皮卡丘, createdTime=Mon May 23 18:57:04 CST 2022, time=2022-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196394, encodeId=c7ba119639409, content=编辑发邮件表示接收并小修，但是邮件里没有提及具体修改的内容，有大佬知道这种情况该怎么办嘛？（已经发过邮件给编辑询问，目前尚无回信）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7b55491270, createdName=yh2, createdTime=Wed Feb 23 13:17:57 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585262, encodeId=975758526257, content=我用在线系统写了两次催稿信，都没有收到回复，求有经验的人指导。一审已经6个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/V1uic8zIRFmrJYfiboenkCicTleYZVXOYQjOiabDgCpFEe9MEASIDy7JBZw1nmgyjG4S69uVQmia7D1lCT1L68ibzvvQ/132, createdBy=950f2163075, createdName=蓝天lzx, createdTime=Mon Feb 24 00:00:00 CST 2020, time=2020-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223113, encodeId=b2db12231137c, content=这个杂志需要的ICMJE表格，one file for each author这是什么意思？每个作者要提交什么啊？😂😅, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23ba8179104, createdName=ms7000001443037924, createdTime=Sun May 29 10:25:09 CST 2022, time=2022-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220163, encodeId=9be2122016386, content=请问这个期刊可以共同通讯作者吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b428152394, createdName=ms2000000257812233, createdTime=Mon May 16 23:55:08 CST 2022, time=2022-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574125, encodeId=a9945e4125e6, content=请问所有的临床实验，都需要注册号吗？非RCT也要？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/V1uic8zIRFmrJYfiboenkCicTleYZVXOYQjOiabDgCpFEe9MEASIDy7JBZw1nmgyjG4S69uVQmia7D1lCT1L68ibzvvQ/132, createdBy=950f2163075, createdName=蓝天lzx, createdTime=Sun Jul 28 00:00:00 CST 2019, time=2019-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1215644, encodeId=9c1e121564402, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：感觉编辑还是很友好的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2b82054649, createdName=果果乖贝儿, createdTime=Fri Apr 29 18:44:29 CST 2022, time=2022-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196399, encodeId=be84119639985, content=请问下有提交不能创建PDf的同学嘛，各位是怎么解决的啊，跪求, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=56145605225, createdName=ms2000001619512986, createdTime=Wed Feb 23 13:28:04 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196403, encodeId=02f71196403fd, content=请问下各位有遇到投稿不能创建PDF的情况吗？跪求解决方案, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=56145605225, createdName=ms2000001619512986, createdTime=Wed Feb 23 13:30:55 CST 2022, time=2022-02-23, status=1, ipAttribution=)]

2022-02-23 ms2000001619512986

请问下有提交不能创建PDf的同学嘛，各位是怎么解决的啊，跪求

38 0

[GetPortalCommentsPageByObjectIdResponse(id=917114, encodeId=5a1c91e11405, content=投稿后被回退：Kindly move the abstract section to the title page. All figure legends should be in order at the end of the text Word doc. They should not be embedded in the actual figures. 不知什么意思，我的图片说明是放在正文最后的，在上传的figure文件中仅仅是以FIG1,FIG2标示，不知要怎样修改, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e9182336216, createdName=1227e9cbm83(暂无昵称), createdTime=Sat Jan 16 10:20:24 CST 2021, time=2021-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221818, encodeId=fb08122181853, content=最近有中稿的同学吗？现在审稿多久呀，从投到接收大概多久呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220217/8786d50a2431425cbaf7dbc437d277a8/068b2a75786546cd8b23afd9cdc1d37b.jpeg, createdBy=30b74770079, createdName=皮卡皮卡丘, createdTime=Mon May 23 18:57:04 CST 2022, time=2022-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196394, encodeId=c7ba119639409, content=编辑发邮件表示接收并小修，但是邮件里没有提及具体修改的内容，有大佬知道这种情况该怎么办嘛？（已经发过邮件给编辑询问，目前尚无回信）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7b55491270, createdName=yh2, createdTime=Wed Feb 23 13:17:57 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585262, encodeId=975758526257, content=我用在线系统写了两次催稿信，都没有收到回复，求有经验的人指导。一审已经6个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/V1uic8zIRFmrJYfiboenkCicTleYZVXOYQjOiabDgCpFEe9MEASIDy7JBZw1nmgyjG4S69uVQmia7D1lCT1L68ibzvvQ/132, createdBy=950f2163075, createdName=蓝天lzx, createdTime=Mon Feb 24 00:00:00 CST 2020, time=2020-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223113, encodeId=b2db12231137c, content=这个杂志需要的ICMJE表格，one file for each author这是什么意思？每个作者要提交什么啊？😂😅, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23ba8179104, createdName=ms7000001443037924, createdTime=Sun May 29 10:25:09 CST 2022, time=2022-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220163, encodeId=9be2122016386, content=请问这个期刊可以共同通讯作者吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b428152394, createdName=ms2000000257812233, createdTime=Mon May 16 23:55:08 CST 2022, time=2022-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574125, encodeId=a9945e4125e6, content=请问所有的临床实验，都需要注册号吗？非RCT也要？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/V1uic8zIRFmrJYfiboenkCicTleYZVXOYQjOiabDgCpFEe9MEASIDy7JBZw1nmgyjG4S69uVQmia7D1lCT1L68ibzvvQ/132, createdBy=950f2163075, createdName=蓝天lzx, createdTime=Sun Jul 28 00:00:00 CST 2019, time=2019-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1215644, encodeId=9c1e121564402, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：感觉编辑还是很友好的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2b82054649, createdName=果果乖贝儿, createdTime=Fri Apr 29 18:44:29 CST 2022, time=2022-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196399, encodeId=be84119639985, content=请问下有提交不能创建PDf的同学嘛，各位是怎么解决的啊，跪求, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=56145605225, createdName=ms2000001619512986, createdTime=Wed Feb 23 13:28:04 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196403, encodeId=02f71196403fd, content=请问下各位有遇到投稿不能创建PDF的情况吗？跪求解决方案, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=56145605225, createdName=ms2000001619512986, createdTime=Wed Feb 23 13:30:55 CST 2022, time=2022-02-23, status=1, ipAttribution=)]

2022-02-23 ms2000001619512986

请问下各位有遇到投稿不能创建PDF的情况吗？跪求解决方案

32 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务